These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15521700)

  • 1. Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease.
    McDermott MM; Greenland P; Guralnik JM; Ferrucci L; Green D; Liu K; Criqui MH; Schneider JR; Chan C; Ridker P; Pearce WH; Martin G; Clark E; Taylor L
    Vasc Med; 2004 May; 9(2):107-15. PubMed ID: 15521700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index.
    McDermott MM; Green D; Greenland P; Liu K; Criqui MH; Chan C; Guralnik JM; Pearce WH; Ridker PM; Taylor L; Rifai N; Schneider JR
    Am J Cardiol; 2003 Jul; 92(2):194-9. PubMed ID: 12860223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.
    McDermott MM; Greenland P; Green D; Guralnik JM; Criqui MH; Liu K; Chan C; Pearce WH; Taylor L; Ridker PM; Schneider JR; Martin G; Rifai N; Quann M; Fornage M
    Circulation; 2003 Jul; 107(25):3191-8. PubMed ID: 12810614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.
    McDermott MM; Ferrucci L; Liu K; Criqui MH; Greenland P; Green D; Guralnik JM; Ridker PM; Taylor LM; Rifai N; Tian L; Zheng J; Pearce WH; Schneider JR; Vonesh E
    J Am Geriatr Soc; 2005 Oct; 53(10):1688-96. PubMed ID: 16181167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease.
    McDermott MM; Ferrucci L; Guralnik JM; Tian L; Green D; Liu K; Tan J; Liao Y; Pearce WH; Schneider JR; Ridker P; Rifai N; Hoff F; Criqui MH
    J Am Coll Cardiol; 2007 Aug; 50(9):897-905. PubMed ID: 17719478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease.
    Unlü Y; Karapolat S; Karaca Y; Kiziltunç A
    Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease.
    Craft LL; Guralnik JM; Ferrucci L; Liu K; Tian L; Criqui MH; Tan J; McDermott MM
    Am J Cardiol; 2008 Nov; 102(9):1263-8. PubMed ID: 18940304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of statin use on mortality in patients with peripheral arterial disease with versus without elevated C-reactive protein and d-dimer levels.
    Vidula H; Tian L; Liu K; Criqui MH; Ferrucci L; Guralnik JM; Green D; Ridker P; McDermott MM
    Am J Cardiol; 2010 May; 105(9):1348-52. PubMed ID: 20403491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.
    Vidula H; Tian L; Liu K; Criqui MH; Ferrucci L; Pearce WH; Greenland P; Green D; Tan J; Garside DB; Guralnik J; Ridker PM; Rifai N; McDermott MM
    Ann Intern Med; 2008 Jan; 148(2):85-93. PubMed ID: 18195333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating blood markers and functional impairment in peripheral arterial disease.
    McDermott MM; Liu K; Ferrucci L; Tian L; Guralnik JM; Green D; Tan J; Liao Y; Pearce WH; Schneider JR; McCue K; Ridker P; Rifai N; Criqui MH
    J Am Geriatr Soc; 2008 Aug; 56(8):1504-10. PubMed ID: 18662216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease.
    McDermott MM; Guralnik JM; Greenland P; Green D; Liu K; Ridker PM; Chan C; Criqui MH; Ferrucci L; Taylor LM; Pearce WH; Schneider JR; Oskin SI
    J Am Geriatr Soc; 2004 Nov; 52(11):1888-94. PubMed ID: 15507067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease.
    Husmann M; Dörffler-Melly J; Kalka C; Diehm N; Baumgartner I; Silvestro A
    J Vasc Surg; 2008 Nov; 48(5):1211-6. PubMed ID: 18771886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer.
    McDermott MM; Liu K; Guralnik JM; Ferrucci L; Green D; Greenland P; Tian L; Criqui MH; Lo C; Rifai N; Ridker PM; Zheng J; Pearce W
    J Gerontol A Biol Sci Med Sci; 2006 Apr; 61(4):374-9. PubMed ID: 16611704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study.
    McDermott MM; Guralnik JM; Corsi A; Albay M; Macchi C; Bandinelli S; Ferrucci L
    Am Heart J; 2005 Aug; 150(2):276-81. PubMed ID: 16086930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease.
    Ye Z; Ali Z; Klee GG; Mosley TH; Kullo IJ
    Am J Hypertens; 2013 Apr; 26(4):495-502. PubMed ID: 23467205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.
    Owens CD; Ridker PM; Belkin M; Hamdan AD; Pomposelli F; Logerfo F; Creager MA; Conte MS
    J Vasc Surg; 2007 Jan; 45(1):2-9; discussion 9. PubMed ID: 17123769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulability markers in patients with peripheral arterial disease: association to ankle-brachial index.
    Mota AP; de Castro Santos ME; Lima e Silva Fd; de Carvalho Schachnik NC; de Oliveira Sousa M; das Graças Carvalho M
    Angiology; 2009; 60(5):529-35. PubMed ID: 19015166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
    Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.